RTS,S/AS01 Malaria Vaccine Mosquirix : If you want to know that whether malaria vaccine is endorsed or approved by World Health Organization or not. Then in this article you will get the complete details about the same. In October, 2021 WHO has given approval for broad use of this RTS,S/AS01 Malaria Vaccine Mosquirix in children to address parasitic infection.
In the above section, As we have given information about the endorsement of mosquirix as malaria vaccine for children. In the further information on this page we have provided all the details like RTS,S Efficacy, how does it work, availability and cost about it. Please go through the further details over this page in order to check complete details about malaria vaccine.
- 1 RTS,S/AS01 Malaria Vaccine Mosquirix :- Overview
- 2 How RTS, S Malaria Vaccine Works & its Mechanism
- 3 RTS, S Malaria Vaccine Efficacy
RTS,S/AS01 Malaria Vaccine Mosquirix :- Overview
|Vaccine Name||RTS, S ( Trade Name Mosquirix )|
|Vaccine Founder||GlaxoSmithKline ( GSK )|
|WHO Endorsement for Mosquirix||Yes in October 2021|
|Vaccine Usage||Address Parasitic Infection|
|Efficacy Rate||36% in children, 26% in Infants|
What Does Malaria Vaccine RTS, S Stands For ?
In this section of article we wanted to share how name RTS, S evolved for Malaria Vaccine Mosquirix. Actually, after scientific study name RTS, S is given logically to this vaccine and it represents its composition. ‘R‘ stands for the central repeat region of Plasmodium Falciparum circumsporozoite protein (CSP); the ‘T’ for the T-cell epitopes of the CSP; and the ‘S’ for hepatitis B surface antigen (HBsAg).
How RTS, S Malaria Vaccine Works & its Mechanism
As per the scientific research it has been found that Malaria is caused by a parasite known as Plasmodium. This is spreaded in the human body through the infected mosquitoes. When Mosquitoes bite over human body it injects Plasmodia in the blood of human being. So, this RTS, S Malaria Vaccine works by inducing antibodies in human for the prevention of Plasmodium Falciparum infection.
RTS, S Malaria Vaccine Efficacy
As far as Malaria Vaccine RTS, S/AS01 Mosquirix efficacy is concerned we want to tell you that this malaria vaccine was already on pilot project as recommended by WHO in selected areas of 3 African countries. After the success of pilot implementation, it has been found that Malaria Vaccine Efficacy is around 36% in children and 24% in infants.
How To Get Rid of Malaria or Plasmodium Infection
As we have provided enough details about the malaria vaccine in the above sections of this article. Here, also we wanted to tell you that in case someone is infected from malaria then how should he/she be treated.
In order to get rid of malaria infection, World Health Organization has recommended RTS,S AS01 Malaria Vaccine Mosquirix as a treatment for it. This vaccine is first and only vaccine that prevents the parasite P. falciparum, which is particularly deadly & prevalent.
This RTS,S malaria vaccine should be provided in a schedule of 4 doses in children from 5 months of age for the reduction of malaria disease.
Is RTS, S Malaria Vaccine Available in India?
RTS, S trade name Mosquirix which has been developed by GlaxoSmithKline (GSK) has recently announced the signing of an agreement to transfer the product malaria vaccine with Bharat Biotech India Ltd (BBIL). That’s a good news for India citizens that Bharat Biotech will also be the manufacturer of RTS,S mosquirix malaria vaccine by year 2029.
As of now Cost of RTS, S/AS01 malaria Vaccine is not yet revealed in India. Most probably cost of 1 dose is expected to be Rupee 350 in India. More details will be shared later once it is officially provided by Indian authority.
FAQs : RTS, S/AS01 Malaria Vaccine
‘R’ stands for the central repeat region of Plasmodium (P.) falciparum circumsporozoite protein (CSP); the ‘T’ for the T-cell epitopes of the CSP; and the ‘S’ for hepatitis B surface antigen (HBsAg).
As per the study, Malaria Vaccine Efficacy is around 36% in children and 24% in infants.
Bharat Biotech India Limited will be producing part of the world’s only malaria vaccine that has been developed by GSK, and was recently approved by WHO.
Cost is not yet revealed by Indian authority. Expected price per shot should be Rs 350 in India.